Inspirata, Inc.
Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System
Tampa, Florida, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,878,025 for its Digital Pathology System. This patent joins Inspirata’s portfolio of nine awarded patents and one patent pending.
Inspirata has been a thought leader in digital pathology for more than a decade, and the Digital Pathology System patent issuance is strong evidence of Inspirata’s contribution to the foundation of the field.
“The issuance of this patent further validates our dedication and commitment to innovation and the advancement of digital pathology as a whole,” said Dr. Mark Lloyd, Executive Vice President and Founder of Inspirata. “This is an important milestone for Inspirata, and we look forward to continuing to expand our growing digital pathology portfolio.”
About Inspirata:
Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.
Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. To learn more, visit www.inspirata.com .
Inspirata Contact:
Emil Mladenov
Vice President of Corporate and Digital Marketing
E-mail: emladenov@inspirata.com
Tel: +1-813-467-7616
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Montreal Heart Institute23.1.2021 07:02:08 CET | Press release
Colchicine reduces the risk of COVID-19-related complications
Zealand Pharma22.1.2021 22:06:25 CET | Press release
Zealand Pharma announces update to 2020 financial guidance
Sveriges Riksbank22.1.2021 20:35:53 CET | Press release
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK TREASURY BILLS
Waturu Holding A/S22.1.2021 19:49:42 CET | Press release
Waturu Holding A/S – convening of an extraordinary general meeting
Waturu Holding A/S22.1.2021 19:49:41 CET | Pressemeddelelse
Waturu Holding A/S – indkaldelse til ekstraordinær generalforsamling
Waturu Holding A/S22.1.2021 19:39:41 CET | Press release
Waturu Holding A/S – change in board of directors
Waturu Holding A/S22.1.2021 19:39:40 CET | Pressemeddelelse
Waturu Holding A/S – ændring i bestyrelsen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom